May 19, 2023
January 25, 2025
This week’s newsletter included:
-
ElevateHER™ Presentation
-
Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield, Appoints Zhenya Lindgardt as Interim CEO
-
U.S. Patent Office Grants Additional Patent Protection for Transit Scientific
-
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
-
Utah Business Features: How Jon Beckstrand Built MasterControl
-
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
-
Biomerics Announces Merger With Precision Concepts Medical
-
Co-Diagnostics Reports First Quarter 2023 Financial Results
-
Michele Baptista Brings Expertise in Early Phase Clinical Trial Services to CenExel Site Network
-
Teva Launches New “Pivot to Growth” Strategy
-
Workforce Services Highlight: Hiring Youth
-
Master of Business Creation (MBC) Adds New Option to Join Online Program in Fall 2023
Featured New Member: SlipStream Medical
Recent News
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services
- RATIO THERAPEUTICS AND NUSANO ENTER LONG-TERM, MULTI-ISOTOPE SUPPLY AGREEMENT TO BOOST PRODUCTION OF CANCER RADIOPHARMACEUTICALS
